Due to the fact that the assessment of those substances has been delayed for reasons beyond the control of the applicants, the approvals of those active substances are likely to expire before a decision has been taken on their renewal. It is therefore necessary to extend their approval periods.
Recital 6, Regulation (EU) 2018/1262
In forcesince 20 Sep 2018